Publications by authors named "Timothy Ferng"

Claim this Profile
S
Single-center experience with nelarabine, etoposide, and cyclophosphamide in adults with relapsed/refractory T-acute lymphoblastic leukemia/lymphoma.
Tamer Othman, Mimi M Lo, Charalambos B Andreadis, Lloyd E Damon, Timothy T Ferng

Leuk Lymphoma· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance Mechanisms.
Timothy T Ferng, Daisuke Terada, Makoto Ando, Theodore C Tarver, Fihr Chaudhary

Mol Cancer Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.
Christine M McMahon, Timothy Ferng, Jonathan Canaani, Eunice S Wang, Jennifer J D Morrissette

Cancer Discov· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput screening for small-molecule inhibitors of LARG-stimulated RhoA nucleotide binding via a novel fluorescence polarization assay.
Chris R Evelyn, Timothy Ferng, Rafael J Rojas, Martha J Larsen, John Sondek

J Biomol Screen· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis